Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CART-meso cells in advanced malignancies
NCT02580747Phase 1Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Oct 2015
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in malignant mesothelioma, pancreatic cancer (PC), ovarian cancer and 2 more, sponsored by Chinese PLA General Hospital. Primary endpoint: Occurrence of Study related adverse events. Status: unknown.
02
Conditions
malignant mesotheliomapancreatic cancer (PC)ovarian cancertriple-negative breast cancer (TNBC)endometrial cancer (EC)
Beyond the preview
Go deeper on NCT02580747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02580747.